Kumamoto University
Also known as: Department nephrology Kumamoto University | Department of Cardiovascular Clinical and Translational Research, Kumamoto University Hospital | Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University | Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University | Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University | Department of Ophthalmology, Kumamoto University Graduate School & Medical Sciences | Department of Pharmacology and Molecular Therapeutics, Graduate School of Medical Sciences, Kumamoto University | Graduate School of Medical Sciences Kumamoto University | Health Care Center / Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University | Kumamoto University | Kumamoto University Graduate School of Medical Sciences | Kumamoto University, Graduate School of Medical Sciences | Kumamoto University Hospital | Professor of Medicine, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University | Saiseikai Kumamoto Hospital
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2001Last known activity
Mar 2, 2020
Timeline
1920s
- Jun 1, 1925
Kumamoto University— Founded
Drugs by trial phase (34 distinct, 22 trials)
Phase 4 (11 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Anemia
- Anemia, Iron-Deficiency
- Arteriosclerosis
- Atherosclerosis
- Breast Neoplasms
- Cardiovascular Diseases
- Colorectal Neoplasms
- Coronary Artery Disease
- Coronary Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Dyslipidemias
- Fatigue
- Hypercholesterolemia
- Hypertension
- Infarction
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia-Lymphoma, Adult T-Cell
- Leukemia, T-Cell
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Myocardial Infarction
- Myocardial Ischemia
- Renal Insufficiency
- Reperfusion Injury
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Syndrome
Recent trials (44)
- NCT05525156CollaboratorPhase 2Mar 2, 2020
- NCT03807804Overall official - principal investigatorPhase 2Jan 1, 2019
- NCT03331718CollaboratorPhase 3Sep 1, 2018
- NCT02514681Overall official - principal investigatorPhase 3Oct 1, 2015
- NCT02565264Lead sponsorEarly Phase 1Sep 30, 2015
- NCT02565264OfficialEarly Phase 1Sep 30, 2015
- NCT02288078Reponsible party - principal investigatorPhase 2Oct 1, 2014
- NCT01984749Study chairN/ANov 1, 2013
- NCT01544309Study chairN/AMar 1, 2012
- NCT01042730CollaboratorN/AJan 1, 2010
- NCT01043380Lead sponsorPhase 4Jan 1, 2010
- NCT01043380Reponsible party - principal investigatorPhase 4Jan 1, 2010
- NCT01043380Study chairPhase 4Jan 1, 2010
- NCT01075698Study chairPhase 4Jul 1, 2009
- NCT01075698Overall official - principal investigatorPhase 4Jul 1, 2009
Details
- Founded
- Kumamoto, JP Jun 1, 1925
- Last known activity
- Mar 2, 2020